Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Mexoryl Xl
2. Silatrizole
1. 155633-54-8
2. Silatrizole
3. Mexoryl Xl
4. Drometrizole Trisiloxane [inci]
5. Drometrizole Trisiloxane [who-dd]
6. 2-(benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[methyl-bis(trimethylsilyloxy)silyl]propyl]phenol
7. Or 10154
8. Or-10154
9. Hc22845i1x
10. Phenol, 2-(2h-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3-(1,3,3,3-tetramethyl-1-((trimethylsilyl)oxy)-1-disiloxanyl)propyl)-
11. Phenol, 2-(2h-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3-(1,3,3,3-tetramethyl-1-((trimethylsilyl)oxy)disiloxanyl)propyl)-
12. 2-(2h-benzo[d][1,2,3]triazol-2-yl)-6-(3-(1,1,1,3,5,5,5-heptamethyltrisiloxan-3-yl)-2-methylpropyl)-4-methylphenol
13. Phenol, 2-(2h-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]-1-disiloxanyl]propyl]-
14. Unii-hc22845i1x
15. Mexoryl Xl;silatrizole
16. Schembl15380
17. Amy224
18. Dtxsid40431753
19. Act12435
20. Bcp28866
21. Db11585
22. Drometrizole Trisiloxane [usp-rs]
23. Ncgc00532508-01
24. Db-091411
25. Drometrizole Trisiloxane, Analytical Standard
26. Q5308268
27. Drometrizole Trisiloxane, United States Pharmacopeia (usp) Reference Standard
28. 2-(2h-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3-(1,3,3,3-tetramethyl-1-(trimethylsilyloxy)-disiloxanyl)propyl)phenol
29. 320341-73-9
| Molecular Weight | 501.8 g/mol |
|---|---|
| Molecular Formula | C24H39N3O3Si3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 9 |
| Exact Mass | 501.22992172 g/mol |
| Monoisotopic Mass | 501.22992172 g/mol |
| Topological Polar Surface Area | 69.4 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 613 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drometrizole trisiloxane is used as an active ingredient in various sunscreens for the indication of protecting the skin by absorbing the damaging UV radiation of sunlight.
As an active ingredient in sunscreen products, drometrizole trisiloxane is applied directly onto human skin where it acts as a chemical sunscreen layer between skin and sunlight that also directly absorbs the UV sunlight radiation. Since drometrizole trisiloxane is also considered to have little to no absorption through the skin, little systemic exposure and pharmacokinetics are expected and users can freely wash off and re-apply the compound as necessary.
Absorption
Drometrizole trisiloxane is reported as having little to no absorption through the skin. At this time, however, studies demonstrate that the components of most commonly used sunscreens are likely absorbed into the skin at least to some extent - although penetration to deeper tissues and the cutaneous circulation remains limited. Despite the extensive use of sunscreen products around the world, there have been few reports of adverse effects related to their use.
Route of Elimination
Drometrizole trisiloxane is reported as having little to no absorption through the skin. The systemic presence of the compound is consequently expected to be minimal.
Volume of Distribution
Drometrizole trisiloxane is reported as having little to no absorption through the skin. The systemic presence of the compound is consequently expected to be minimal.
Clearance
Drometrizole trisiloxane is reported as having little to no absorption through the skin. The systemic presence of the compound is consequently expected to be minimal.
Drometrizole trisiloxane is reported as having little to no absorption through the skin. The systemic presence of the compound is consequently expected to be minimal.
Drometrizole trisiloxane is reported as having little to no absorption through the skin. The systemic presence of the compound is consequently expected to be minimal.
Ultraviolet radiation is the invisible energy component to sunlight and consists of three wavelength ranges: (a) UVA is long-range UV radiation between 320-400nm. Although not as energetic as UVB, UVA can penetrate deep into the dermis. UVA can cause immediate tanning, premature skin aging, and can also play a role in the formation of some skin cancers. Approximately 95% of UVA from the sun passes through Earth's ozone layer. (b) UVB is short-wavelength UV radiation between 280-320nm. It is capable of penetrating the outer protective layer of the skin and is responsible for delayed tanning, sunburns, and most skin cancers. A large amount of UVB is absorbed by the ozone layer, however, as only 5% reaches the Earth's surface. (c) UVC is comprised of wavelengths between 100-280nm and is very energetic. It is very dangerous to all forms of life, even when the exposure is short. However, UVC radiation is generally filtered out by the ozone layer and never reaches the Earth. Ultimately, the shorter the wavelength, the more harmful the UV radiation - although shorter wavelength UV radiation is less able to penetrate the skin. Subsequently, drometrizole trisiloxane is a broad spectrum lipophilic benzotriazole derivative chemical sunscreen that is capable of absorbing UVA and UVB radiation. It is also photostable, meaning that it will not degrade in the presence of sunlight, unlike other UV filters like the widely used UVA absorber avobenzone. When combined with the UV blocker ecamsule, it has been shown that the two UV blockers elicit a synergistic effect involving an enhanced protective action for the skin against UVA and UVB radiation. Additionally, drometrizole trisiloxane is usually combined with other active sunscreen agents like titanium dioxide, avobenzone, and others to ensure the combined product covers or protects against as broad a spectrum of UV radiation as possible, considering drometrizole trisiloxane does not absorb against the entire range of UV radiation. And finally, at the molecular level, it is believed that the general structure of various UV blockers like drometrizole trisiloxane as aromatic molecules conjugated with carbonyl groups is capable of absorbing high energy ultraviolet rays and then consequently releasing that energy as less harmful, lower energy rays.
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : SPF 60 ANTHELIOS XL LOTION
Dosage Form : LOTION
Dosage Strength : 2.5%/W/W
Packaging : 100ML
Approval Date :
Application Number : 2402157
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : OMBRELLE CREAM SPF 60
Dosage Form : CREAM
Dosage Strength : 3%
Packaging : 75ML
Approval Date :
Application Number : 2280353
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : SPF 45 SPORT CLEAR CONTINUOUS SPRAY
Dosage Form : AEROSOL
Dosage Strength : 1%
Packaging : 140ML
Approval Date :
Application Number : 2374196
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : SPORT CLEAR SPRAY SUNSCREEN
Dosage Form : AEROSOL
Dosage Strength : 2%/W/W
Packaging :
Approval Date :
Application Number : 2374218
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : FPS 30 SOIN COMPLET
Dosage Form : LOTION
Dosage Strength : 2.5%/W/W
Packaging : 240ML
Approval Date :
Application Number : 2410044
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : FPS 60 SOIN COMPLET
Dosage Form : LOTION
Dosage Strength : 2.5%/W/W
Packaging : 240ML
Approval Date :
Application Number : 2410060
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : SPF 30 SPORT ENDURANCE
Dosage Form : LOTION
Dosage Strength : 0.5%/W/W
Packaging : 231ML
Approval Date :
Application Number : 2447770
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : SPF 60 SPORT ENDURANCE
Dosage Form : LOTION
Dosage Strength : 0.5%/W/W
Packaging : 231ML
Approval Date :
Application Number : 2447843
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : ULTRA LIGHT ADVANCED CONTINUOUS SPRAY LOTION
Dosage Form : LOTION
Dosage Strength : 0.5%/W/W
Packaging :
Approval Date :
Application Number : 2448718
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : BARE SKIN FEEL UV LOTION
Dosage Form : LOTION
Dosage Strength : 2.5%/W/W
Packaging : 150ML
Approval Date :
Application Number : 2401916
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : FPS 30 SOIN COMPLET
Dosage Form : LOTION
Dosage Strength : 2.5%/W/W
Packaging : 240ML
Approval Date :
Application Number : 2410044
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : SPF 60 SPORT ENDURANCE
Dosage Form : LOTION
Dosage Strength : 0.5%/W/W
Packaging : 231ML
Approval Date :
Application Number : 2447843
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : COMPLETE* DRY TOUCH SUNSCREEN/ÉCRAN SOLAIRE
Dosage Form : LOTION
Dosage Strength : 0.5%/W/W
Packaging :
Approval Date :
Application Number : 2461048
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : SPF 50+ KIDS (80 MINUTES) WATER RESISTANT
Dosage Form : SPRAY
Dosage Strength : 0.5%/W/W
Packaging : 122G
Approval Date :
Application Number : 2464322
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : COMPLETE SENSITIVE ADVANCED [80 MINUTES] WATER/SWEAT RESISTANT LOTION SPF 60
Dosage Form : LOTION
Dosage Strength : 0.5%/W/W
Packaging : 200ML
Approval Date :
Application Number : 2465884
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : FACE ANTI-SHINE CREAM
Dosage Form : CREAM
Dosage Strength : 0.5%/W/W
Packaging :
Approval Date :
Application Number : 2489589
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : SENSITIVE EXPERT+ FACE
Dosage Form : CREAM
Dosage Strength : 0.5%/W/W
Packaging :
Approval Date :
Application Number : 2507439
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : ULTRA LIGHT ADVANCED LOTION
Dosage Form : LOTION
Dosage Strength : 7%/W/W
Packaging :
Approval Date :
Application Number : 2509237
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : BARE SKIN FEEL UV LOTION
Dosage Form : LOTION
Dosage Strength : 2.5%/W/W
Packaging : 150ML
Approval Date :
Application Number : 2401916
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : ANTI-SHINE DRY TOUCH UV LOTION
Dosage Form : LOTION
Dosage Strength : 0.5%/W/W
Packaging : 50ML
Approval Date :
Application Number : 2466406
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Application : Direct Compression
Excipient Details : DC SIM 100 is a directly compressible simethicone powder used for antacid and anti-gas tablets.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Thickeners and Stabilizers
Excipient Details : Used as a chelating agent in cell culture media, downstream and as a chelator stabilizer in Biopharmaceutical formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Disodium Edetate Excipient
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Parenteral, Thickeners and Stabilizers
Application : Parenteral, Thickeners and Stabilizers
Excipient Details : Used as a chelating agent in cell culture media, downstream and as a chelator stabilizer in Biopharmaceutical formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Disodium Edetate Excipient
Dosage Form : Cream / Lotion / Ointment, Gel
Grade : Topical
Category : Thickeners and Stabilizers, Topical
Brand Name : Carbopol Ultrez 10 NF
Application : Thickeners and Stabilizers, Topical
Pharmacopoeia Ref : United States Pharmacopeia/Nat...
Technical Specs : Viscosity, cP (0.5 wt% at pH 7.5) - 45000 - 65,000
Ingredient(s) : CARBOMER INTERPOLYMER TYPE A
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
32
PharmaCompass offers a list of Silatrizole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Silatrizole manufacturer or Silatrizole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Silatrizole manufacturer or Silatrizole supplier.
A Drometrizole trisiloxane [INCI] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Drometrizole trisiloxane [INCI], including repackagers and relabelers. The FDA regulates Drometrizole trisiloxane [INCI] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Drometrizole trisiloxane [INCI] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Drometrizole trisiloxane [INCI] supplier is an individual or a company that provides Drometrizole trisiloxane [INCI] active pharmaceutical ingredient (API) or Drometrizole trisiloxane [INCI] finished formulations upon request. The Drometrizole trisiloxane [INCI] suppliers may include Drometrizole trisiloxane [INCI] API manufacturers, exporters, distributors and traders.
Drometrizole trisiloxane [INCI] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Drometrizole trisiloxane [INCI] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Drometrizole trisiloxane [INCI] GMP manufacturer or Drometrizole trisiloxane [INCI] GMP API supplier for your needs.
A Drometrizole trisiloxane [INCI] CoA (Certificate of Analysis) is a formal document that attests to Drometrizole trisiloxane [INCI]'s compliance with Drometrizole trisiloxane [INCI] specifications and serves as a tool for batch-level quality control.
Drometrizole trisiloxane [INCI] CoA mostly includes findings from lab analyses of a specific batch. For each Drometrizole trisiloxane [INCI] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Drometrizole trisiloxane [INCI] may be tested according to a variety of international standards, such as European Pharmacopoeia (Drometrizole trisiloxane [INCI] EP), Drometrizole trisiloxane [INCI] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Drometrizole trisiloxane [INCI] USP).